Relationship between type 2 diabetes mellitus and markers of cutaneous melanoma aggressiveness: an observational multicentric study in 443 patients with melanoma.

E NagoreMiguel Ángel Martínez-GarcíaJ D Gomez-OlivasE Manrique-SilvaA MartorellJ BañulsC CarreraP OrtizJ GardeazabalA BoadaE de EusebioE ChinerC GonzalezA Pérez-GilD CullenM FormigónB de UnamunoC Navarro-SorianoA MurielD Gozal

Published in: The British journal of dermatology (2021)

T2DM, rather than glycaemic control and metformin treatment, is associated with increased cutaneous melanoma aggressiveness at diagnosis.

Keyphrases

skin cancer
type diabetes
glycemic control
basal cell carcinoma
metabolic syndrome